In 2020, the global Dried Blood Spot Collection Cards Market was valued at USD 277.2 Million. It is projected to experience a compound annual growth rate (CAGR) of 3.8% during the forecast period. Factors such as the increasing number of newborn babies, growing demand for infectious disease screening, and the preference for non-invasive blood testing methods are expected to drive the revenue growth of this market.
The screening of congenital and metabolic diseases in newborns has seen a significant rise due to the potential benefits of early-stage diagnosis and treatment. Dried blood spot collection offers a quick and accurate alternative to conventional blood testing, eliminating the need for retesting and leading to its widespread adoption. These factors are anticipated to contribute to the market's future revenue growth.
Dried Blood Spot Testing (DBS) is a method of biosampling where blood samples are collected by blotting and drying them on filter paper. These dried samples are then securely transported to analytical laboratories for analysis using DNA amplification or HPLC techniques. The concept of using capillary blood obtained from finger or heel pricks and blotting it on filter paper for screening metabolic diseases was first introduced in 1963.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/4054
Competitive Landscape:
The global dried blood spot collection cards market is fragmented and comprises several major players operating on global and regional levels. Key players are focusing on RD activities, technological developments and advancements, and strategic alliances such as mergers acquisitions, collaborations, and partnerships to expand their respective product portfolios to cater to rising global demand and to gain a robust foothold in the market. Major companies operating in the market include Qiagen, PerkinElmer, Inc., Roche AG, Shimadzu Corporation (Novilytic Labs), Ahlstrom-Munksjö, Pall Corporation, Eastern Business Forms, Inc., ARCHIMEDlife, and Centogene AG.
To know more about the report @ https://www.reportsanddata.com/report-detail/dried-blood-spot-collection-cards-market
Driving Factors of the Dried Blood Spot Collection Cards Market:
- Increasing Number of Newborn Babies: The growing population of newborn babies creates a higher demand for newborn screening tests, including the use of dried blood spot collection cards. As healthcare systems focus on early detection and management of diseases in infants, the market for these cards is expected to expand.
- Rising Demand for Screening for Infectious Diseases: Dried blood spot collection cards are commonly used for screening infectious diseases such as HIV, hepatitis, and syphilis. The increasing prevalence of these diseases, along with the need for efficient and cost-effective screening methods, drives the demand for dried blood spot collection cards.
- Preference for Non-Invasive Blood Testing Methods: Compared to traditional blood testing methods that require venipuncture, dried blood spot collection offers a non-invasive alternative. Many patients and healthcare providers prefer this method as it is less invasive, more convenient, and requires smaller sample volumes.
- Quick and Accurate Testing: Dried blood spot collection cards provide a rapid and accurate method for blood testing. The cards are designed to preserve the stability of blood samples, ensuring reliable results. Their convenience and accuracy contribute to their growing adoption in various healthcare settings.
Restraints of the Dried Blood Spot Collection Cards Market:
- Limited Diagnostic Capabilities: While dried blood spot collection cards are useful for certain types of screening and diagnostic tests, they may have limitations in terms of the range of diseases and conditions they can detect. Some diagnostic tests may require larger sample volumes or more sophisticated testing methods, which may not be feasible with dried blood spot cards.
- Standardization and Quality Control Challenges: Maintaining consistent quality and standardization across different dried blood spot collection cards and laboratory procedures can be challenging. Variability in sample collection techniques, storage conditions, and laboratory protocols can impact the accuracy and reliability of test results.
- Regulatory and Ethical Considerations: The use of dried blood spot collection cards for newborn screening and disease testing raises regulatory and ethical considerations. Ensuring proper consent, privacy, and confidentiality of patient information, as well as compliance with local regulations and guidelines, can pose challenges for market growth.
- Limited Awareness and Adoption in Certain Regions: The adoption of dried blood spot collection cards may vary across different regions and healthcare settings. Some areas may have limited awareness or infrastructure to support the use of these cards, hindering their market growth potential in those regions.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4054
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
